ANKRD27 and hepatocellular carcinoma: Importantly, in both TCGA-HCC cohort, external cohort, and GSE14520 cohort, patients with high ANKRD27 expression exhibited poorer survival probability, suggesting the potential of ANKRD27 as a prognostic biomarker in HCC.